Neural Therapeutics wins CSE conditional approval for Hanf.com acquisition deal
Reuters2026/08/14 21:01- Neural Therapeutics received conditional CSE clearance to list shares tied to its planned acquisition of remaining equity in CWE European Holdings.
- The deal would make CWE, operator of Hanf.com in Germany, a wholly owned subsidiary; Neural plans to rename to Hanf.com.
- Conditions include completing the concurrent financing, required escrow arrangements, and SEDAR+ filings; the CSE will set a post-close trading date.
- Neural shareholders backed the transaction on May 25, 2026, including a proposed share consolidation and the Hanf.com name change.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Data: The current Crypto Fear & Greed Index is 68, indicating a state of greed.
The global autonomous driving battle intensifies! Alphabet's Waymo teams up with a Japanese giant to seize the Tokyo market.
Waymo, a subsidiary of Alphabet, announced a partnership with a major Japanese taxi company to launch autonomous driving services in Tokyo in 2027. Following the news, shares of its partner, Go, surged by 9.7%.
Treasury Firms Stack Ethereum, Solana, and Bitcoin Through a Jittery September Market
UOB Kay Hian: Maintains "Buy" rating for Waterdrop (WDH.US), raises target price to $2.23
Based on revised profit forecasts, UOB Kay Hian has maintained its “Buy” rating on Waterdrop and raised the target price to $2.23.
Crypto prices
More
